Work as Dy.Manager/ Manager-Projects in Pharma company- Onlypharmajob
Reputed Pharma Consultant
Post: Dy.Manager/ Manager-Projects (12-18 years) - 02 posts
[adsense:336x280:8701650588]
Pembrolizumab (trade name: Keytruda) was initially introduced for the treatment of melanoma. Since July 2016, the monoclonal antibody has also been available for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in adults whose tumours express the T-cell receptor ligand PD-L1 and who have received a prior chemotherapy regimen. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy also for these patients.